- Erratum
- Open access
- Published:
Erratum to: JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
Breast Cancer Research volume 18, Article number: 114 (2016)
The Original Article was published on 30 May 2014
In the original publication of the article [1], we noticed an error to Table 2. The numbers for each ARHI staining in the subtypes of JMJD2A were mistakenly copied from another molecular which we were simultaneously working on. This mistake went unfortunately unnoticed in the thereafter review and proofreading processes. The Table 2 shown in this erratum is the correct representation of the data from this study. The authors apologize for this error.
As a consequence, the sentence in the left column of Page 6 of 14 of the article PDF, line 4-6, should be accordingly corrected to be “Spearman correlation analysis showed that expression of JMJD2A was inversely correlated with expression of ARHI (p = 0.021, r = -0.185, Table 2)”.
References
Li et al. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI. Breast Cancer Research. 2014; 16:R56
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/bcr3667.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Li, LL., Xue, AM., Li, BX. et al. Erratum to: JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI. Breast Cancer Res 18, 114 (2016). https://0-doi-org.brum.beds.ac.uk/10.1186/s13058-016-0776-3
Received:
Accepted:
Published:
DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13058-016-0776-3